Irish pharma sector 'can survice patent cliff'

Economists and industry experts say the Irish pharmaceutical sector can survive the so-called "patent cliff".

It follows the news that 150 jobs are to go at Pfizer's Newbridge plant; and the loss of almost a thousand jobs at MSD in Dublin and Wicklow over the next four years.